What public sources say about the safety of zinc: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.
Interactions and safety, in NIH's words
Zinc may interact with certain medications, such as quinolone antibiotics, tetracycline antibiotics, and penicillamine. In addition, some diuretics can decrease serum zinc concentrations by increasing zinc excretion in urine.
Zinc has the potential to interact with certain medications. In addition, several types of medications might adversely affect zinc levels. A few examples are provided below. Individuals who are taking these and other medications on a regular basis should discuss their zinc status with their health care providers.
Both quinolone antibiotics (such as Cipro) and tetracycline antibiotics (such as Achromycin and Sumycin) might interact with zinc in the gastrointestinal tract, which could inhibit the absorption of both zinc and the antibiotic if they are taken at the same time [103,104]. Taking the antibiotic at least 2 hours before or 4 to 6 hours after the zinc supplement minimizes this interaction [103].
Medicines covered in that section: Antibiotics, Penicillamine, Diuretics.
Quoted from the “Interactions with Medications” section: NIH Office of Dietary Supplements, health-professional fact sheet, retrieved 2026-11-16. Read the full page for the complete list and references.
FDA adverse-event reports (CAERS)
Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “ZINC”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.
Combination products: 388 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 132 reports where a product is named for zinc alone. This split is made from product names and can misfile some products. Most-reported products: Emergen-C (136); Caltrate 600 Plus Chewable (21); Puritan'S Pride Zinc (16); Caltrate Plus (14); Emergen-C Ascorbic Acid B-Complex Electrolyte Multimineral Multivitamin Zinc Powder For Oral Solution (14); Zinc (13).
| Most reported reactions (single-ingredient products) | Reports |
|---|---|
| Vomiting | 24 |
| Nausea | 22 |
| Diarrhoea | 16 |
| Malaise | 15 |
| Dizziness | 13 |
| Abdominal pain upper | 13 |
| Choking | 12 |
| Foreign body | 11 |
| Dyspnoea | 11 |
| Fatigue | 10 |
| Asthenia | 8 |
| Loss of consciousness | 7 |
Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (76), Hospitalization (33), Visited Emergency Room (30), Visited a Health Care Provider (30), Other Serious Outcome (27), Life Threatening (24), Disability (7), Other Outcome (6).
Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.
Registered trials
17 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.
- IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity Completed Results posted
- Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity Completed Results posted
- Age-Related Eye Disease Study (AREDS) Completed
- Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia Completed
- Zinc Supplements in Lowering Cadmium Levels in Smokers Completed
- Development of a Celiac Safe Food Additive Completed
- Zinc Supplement in Regorafenib Treated mCRC Patient Completed
- Polaprezinc (Zinc L-carnosine) in Infants With Gastroesophageal Reflux Completed
- Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) Completed
- Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer Completed
- Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients Completed
- Zinc Therapy in Critical Illness Completed
- Zinc for Infection Prevention in Sickle Cell Anemia (ZIPS) Completed
- Prevention of Oral Mucositis in Head and Neck Cancer. Recruiting
- Zn Supplementation in HIV Immunological Non Responders Recruiting
- Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Status unknown
- The Impact of Zinc Supplementation on Innate Immunity and Patient Safety in Sepsis Terminated